Cargando…
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428596/ https://www.ncbi.nlm.nih.gov/pubmed/32233753 http://dx.doi.org/10.1161/JAHA.120.016509 |
_version_ | 1783571109869780992 |
---|---|
author | Sommerstein, Rami Kochen, Michael M. Messerli, Franz H. Gräni, Christoph |
author_facet | Sommerstein, Rami Kochen, Michael M. Messerli, Franz H. Gräni, Christoph |
author_sort | Sommerstein, Rami |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7428596 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74285962020-08-17 Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? Sommerstein, Rami Kochen, Michael M. Messerli, Franz H. Gräni, Christoph J Am Heart Assoc Viewpoints John Wiley and Sons Inc. 2020-04-01 /pmc/articles/PMC7428596/ /pubmed/32233753 http://dx.doi.org/10.1161/JAHA.120.016509 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Viewpoints Sommerstein, Rami Kochen, Michael M. Messerli, Franz H. Gräni, Christoph Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title | Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title_full | Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title_fullStr | Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title_full_unstemmed | Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title_short | Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect? |
title_sort | coronavirus disease 2019 (covid‐19): do angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect? |
topic | Viewpoints |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428596/ https://www.ncbi.nlm.nih.gov/pubmed/32233753 http://dx.doi.org/10.1161/JAHA.120.016509 |
work_keys_str_mv | AT sommersteinrami coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect AT kochenmichaelm coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect AT messerlifranzh coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect AT granichristoph coronavirusdisease2019covid19doangiotensinconvertingenzymeinhibitorsangiotensinreceptorblockershaveabiphasiceffect |